Soluble plasma programmed death 1 (PD-1) and Tim-3 in primary HIV infection

Soluble plasma programmed death 1 (PD-1) and Tim-3 in primary HIV infection

Soluble forms of the coinhibitory receptors programmed death 1 (PD-1) and Tim-3 exist, but their relationship with T-cell surface expression remains unclear. When measured by an enzyme-linked immunosorbent assay in plasma, soluble PD-1, and soluble Tim-3 were elevated during primary HIV infection, d...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Frater, J, Martin, GE, Willberg, CB, Zilber, E, Fox, J, Nwokolo, N, Fidler, S, CHERUB Investigators
Natura:	Journal article
Lingua:	English
Pubblicazione:	Lippincott, Williams & Wilkins 2019

Documenti analoghi

Persistent elevation of Tim-3 and PD-1 on memory T cells despite early ART initiation during primary HIV infection
di: G.E. Martin, et al.
Pubblicazione: (2019-07-01)

Enrichment of the HIV reservoir in CD32+CD4 T cells occurs early and is closely associated with immune checkpoint receptor expression
di: Martin, GE, et al.
Pubblicazione: (2017)

Exhaustion of Activated CD8 T Cells Predicts Disease Progression in Primary HIV-1 Infection.
di: Matthias Hoffmann, et al.
Pubblicazione: (2016-07-01)

OA1-2 Enrichment of the HIV reservoir in CD32+ CD4 T cells occurs early and is closely associated with immune checkpoint receptor expression
di: G.E. Martin, et al.
Pubblicazione: (2017-07-01)

Early antiretroviral therapy reduces hiv dna following perinatal HIV infection
di: Foster, C, et al.
Pubblicazione: (2017)

Histone Deacetylase Inhibitors Enhance CD4 T Cell Susceptibility to NK Cell Killing but Reduce NK Cell Function.
di: Matthew Pace, et al.
Pubblicazione: (2016-08-01)

Serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death ligand 1 (sPD-L1) in advanced pancreatic cancer
di: Stephan Kruger, et al.
Pubblicazione: (2017-05-01)

Levels of human immunodeficiency virus DNA are determined before art initiation and linked to CD8 T-cell activation and memory expansion
di: Martin, GE, et al.
Pubblicazione: (2019)

Targeting Tim-3 in Cancer With Resistance to PD-1/PD-L1 Blockade
di: Tian Tian, et al.
Pubblicazione: (2021-09-01)

Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy
di: Riyao Yang, et al.
Pubblicazione: (2021-02-01)

Soluble programmed death-1 (sPD-1) and programmed death ligand 1 (sPD-L1) as potential biomarkers for the diagnosis and prognosis of glioma patients
di: Liu Shujun, et al.
Pubblicazione: (2020-01-01)

Systemic levels of the soluble co-inhibitory immune checkpoints, CTLA-4, LAG-3, PD-1/PD-L1 and TIM-3 are markedly increased in basal cell carcinoma
di: Nonkululeko Z. Malinga, et al.
Pubblicazione: (2022-05-01)

Therapeutic plasma exchange clears circulating soluble PD-L1 and PD-L1-positive extracellular vesicles
di: Haidong Dong, et al.
Pubblicazione: (2020-10-01)

Exhaustion of activated CD8 T cells predicts disease progression in primary HIV-1 infection
di: Hoffmann, M, et al.
Pubblicazione: (2016)

HIV-1 drug resistance in primary infections in the UK.
di: Fidler, S, et al.
Pubblicazione: (2001)

Increased Plasma Soluble PD-1 Concentration Correlates with Disease Progression in Patients with Cancer Treated with Anti-PD-1 Antibodies
di: Ryotaro Ohkuma, et al.
Pubblicazione: (2021-12-01)

Soluble forms of immune checkpoint receptor PD-1 and its ligand PD-L1 in plasma of patients with ovarian neoplasms
di: E. S. Gershtein, et al.
Pubblicazione: (2018-12-01)

CD32 expressing doublets in HIV-infected gut-associated lymphoid tissue are associated with a T follicular helper cell phenotype
di: Thornhill, J, et al.
Pubblicazione: (2019)

The impact of vorinostat and therapeutic vaccine on gut HIV DNA: the RIVER gut study
di: Thornhill, J, et al.
Pubblicazione: (2019)

The Clinical Significance of Soluble Programmed Cell Death-Ligand 1 (sPD-L1) in Patients With Gliomas
di: Shujun Liu, et al.
Pubblicazione: (2020-01-01)

PD-1 and Tim-3 Pathways Regulate CD8+ T Cells Function in Atherosclerosis.
di: Ming-Ke Qiu, et al.
Pubblicazione: (2015-01-01)

The potential of soluble programmed death-ligand 1 (sPD-L1) as a diagnosis marker for colorectal cancer
di: Weifang Shao, et al.
Pubblicazione: (2022-08-01)

Soluble programmed death molecule 1 (sPD-1) as a predictor of interstitial lung disease in rheumatoid arthritis
di: Li Xu, et al.
Pubblicazione: (2021-10-01)

Biological Characteristics and Clinical Significance of Soluble PD-1/PD-L1 and Exosomal PD-L1 in Cancer
di: Mengke Niu, et al.
Pubblicazione: (2022-03-01)

Deciphering molecular and cellular ex vivo responses to bispecific antibodies PD1-TIM3 and PD1-LAG3 in human tumors
di: Alfred Zippelius, et al.
Pubblicazione: (2022-11-01)

The Role of the Immune Checkpoint Molecules PD-1/PD-L1 and TIM-3/Gal-9 in the Pathogenesis of Preeclampsia—A Narrative Review
di: Johanna Mittelberger, et al.
Pubblicazione: (2022-01-01)

The interaction between the soluble programmed death ligand-1 (sPD-L1) and PD-1+ regulator B cells mediates immunosuppression in triple-negative breast cancer
di: Xuejiao Li, et al.
Pubblicazione: (2022-07-01)

Altered expression of Tim family molecules and an imbalanced ratio of Tim-3 to Tim-1 expression in patients with type 1 diabetes
di: Yikai Liu, et al.
Pubblicazione: (2022-07-01)

In vitro Interactions of Chicken Programmed Cell Death 1 (PD-1) and PD-1 Ligand-1 (PD-L1)
di: Vishwanatha R. A. P. Reddy, et al.
Pubblicazione: (2019-12-01)

The Prognostic Value of Serum Soluble Programmed Death 1 (sPD‐1) and Programmed Death Ligand 1 (sPD‐L1) in Esophageal Squamous Cell Carcinoma: A Systematic Review and Meta‐Analysis About Cohort Studies
di: Qiyao Yu, et al.
Pubblicazione: (2024-11-01)

Mast cell activation is enhanced by Tim1:Tim4 interaction but not by Tim-1 antibodies [version 2; referees: 2 approved]
di: Binh Phong, et al.
Pubblicazione: (2016-07-01)

Dual but not single PD-1 or TIM-3 blockade enhances oncolytic virotherapy in refractory lung cancer
di: Zong Sheng Guo, et al.
Pubblicazione: (2020-05-01)

PD-1 AND Tim-3 Expression on different subpopulations of monocytes in chronic often recurrent herpesvirus infection
di: Ivan M. Rashchupkin, et al.
Pubblicazione: (2024-07-01)

Immune Checkpoint Receptors Tim-3 and PD-1 Regulate Monocyte and T Lymphocyte Function in Septic Patients
di: Qi Xia, et al.
Pubblicazione: (2018-01-01)

A higher number of exhausted local PD1+, but not TIM3+, NK cells in advanced endometriosis
di: Ramin Hosseinzadeh, et al.
Pubblicazione: (2024-01-01)

Expression of inhibitory receptors PD-1, CTLA-4, and Tim-3 by peripheral T cells during pregnancy
di: E. A. Smetanenko, et al.
Pubblicazione: (2022-10-01)

Peripheral PD-1 and Tim-3 percentages are associated with primary sites and pathological types of peritoneal neoplasms
di: Huihui Hu, et al.
Pubblicazione: (2023-03-01)

TIM3 expression on tumor cells predicts response to anti-PD-1 therapy for renal cancer
di: Renpei Kato, et al.
Pubblicazione: (2021-01-01)

Serum Concentrations of TIM-3, LAG-3, and PD-1 in Patients with Hemorrhagic Fever with Renal Syndrome
di: Željka Mačak Šafranko, et al.
Pubblicazione: (2024-04-01)

The role of the gut mucosa in protection from HIV-1 in highly exposed persistently seronegative individuals (HEPS)
di: Fox, J, et al.
Pubblicazione: (2009)